U.S. STOCKS ON THE MOVE-Bed Bath & Beyond, Foghorn Therapeutics, Bluebird Bio

Blue Circle Services

24/04/2023 14:29

* 
      Eikon search string for individual stock moves:  STXBZ 
    

        * 
      The Day Ahead newsletter: https://refini.tv/3LI4BU7
    

        * 
      The Morning News Call newsletter: https://refini.tv/3dKUyB8
    

  
Wall Street was set for a muted open on Monday ahead of a busy week for
earnings, with investors also awaiting key data that could shed light on the
U.S. economy and shape the Federal Reserve's monetary policy.  .N 
    
    At 9:13 a.m. ET, Dow e-minis  1YMc1  were down 0.06% at 33,928. S&P 500
e-minis  ESc1  were unchanged at 4,156.75, while Nasdaq 100 e-minis  NQc1  were
up 0.02% at 13,092.75.
 
 The top three NYSE percentage gainers premarket  .PRPG.NQ :
 ** Getty Images Holdings Inc  GETY.N , up 57.7%
 ** Koninklijke Philips NV  PHG.N , up 13.8%
 ** Getaround Inc  GETR.N , up 11.0%
 
 The top three NYSE percentage losers premarket  .PRPL.NQ :
 ** MonyLion Inc  ML.N , down 14.4%
 ** C3ai Inc  AI.N , down 7.6%
 ** Annovis Bio Inc  ANVS.N , down 6.4%
 
 The top Nasdaq percentage gainers premarket  .PRPG.O :
 ** Tempo Automation Holdings Inc  TMPO.O , up 98.6%
 ** In8bio Inc  INAB.O , up 70.5%
 ** Aclarion Inc  ACON.O , up 68.8% 
    
 The top three Nasdaq percentage losers premarket  .PRPL.O :
 ** Bed Bath & Beyond Inc  BBBY.O , down 24.4%
 ** Femasys Inc  FEMY.O , down 20%
 ** Presto Automation Inc  PRST.O , down 16.6% 
 
 
 ** Bed Bath & Beyond Inc  BBBY.O : down 25.5% premarket
 BUZZ - Bed Bath & Beyond tumbles after co files for bankruptcy protection
 urn:newsml:reuters.com:*:nL4N36R1J4
    
 ** Bluebird bio Inc  BLUE.O : up 10.5% premarket
 BUZZ - Bluebird bio up on submitting marketing application for blood disorder
gene therapy  urn:newsml:reuters.com:*:nL4N36R2IH
 
 ** Foghorn Therapeutics  FHTX.O : down 17.1% premarket
 BUZZ - Foghorn Therapeutics falls on pausing enrollment in cancer study
 urn:newsml:reuters.com:*:nL4N36R2DI
    
 ** IDEAYA Biosciences Inc  IDYA.O  up 14.9% premarket 
 BUZZ - IDEAYA Biosciences up on promising data from eye cancer drug study
 urn:newsml:reuters.com:*:nL4N36R2S2

 (Compiled by Pratik Jain in Bengaluru)
 ((Pratik.Jain@thomsonreuters.com;))